// Peaky Finance · Live feed
Monthly Recap
The bigger picture. Zoom out from the daily signals to what the month actually said, where momentum built, where money rotated, and which themes are worth watching.
Show this month's momentum recap
The first monthly recap is coming soon. The live stream runs 24/7 on Telegram, and each weekly recap feeds into it.
Near their 52-week lows, August 2026
Thirty large-cap names trading close to their 52-week lows, screened on valuation, insider activity and what actually drove the decline. The distinction that matters is between a multiple de-rating, where the market has simply repriced the shares, and a genuine deterioration in fundamentals. Prices are verified as of 31 August 2026. P/E is shown trailing / forward, P/B is price-to-book, and the insider column covers the last six months. Any reference to forward growth is a scenario drawn from company guidance and analyst consensus, not a forecast.
| Ticker | Price | P/E (TTM / Fwd) | P/B | Insider (6m) | Read |
|---|---|---|---|---|---|
| META | $571.80 | 21.5 / 19.1 | 5.6 | Selling (CFO) | Trades below its ten-year average multiple despite roughly 20% revenue growth; the overhang is up to $135B of AI capex and CFO selling, not the underlying business. |
| HD | $327.97 | 23.1 / n/a | ~20 | Selling (CEO) | A housing-cycle de-rating with the multiple in line with its own history; operating cash flow and buybacks stay intact while DIY demand normalises. |
| APP | $310.80 | ~20 / 20.0 | ~33 | Heavy selling (~$372M) | Down 54% YTD on short-seller allegations and multiple compression, even as Q3 revenue is guided +46–48% year over year; the ~$372M of insider selling is the caution flag. |
| MCD | $265.73 | 21.1 / 20.1 | n/a | 15 sells, 0 buys | Soft US traffic and margin pressure alongside fifteen insider sales and no buys; aggressive buybacks have pushed book value negative, so P/B is not meaningful. |
| LHX | $267.28 | 26.5 / 22.5 | 2.5 | Selling | Profit-taking after a strong run, set against raised FY26 guidance and Q2 free cash flow up 37%; a cyclical pullback rather than a broken thesis. |
| IBM | $234.38 | 21.2 / 19.4 | 6.3 | n/a | Sold off after 2026 guidance was trimmed to 4–5% constant-currency growth; free cash flow is still building, but the growth premium has come out of the stock. |
| LOW | $205.82 | 17.6 / n/a | n/a | Selling (CEO) | FY26 guidance cut on soft DIY demand; buybacks have driven book value negative and the CEO has been selling. |
| HON | $213.45 | 8.0 / 19.2 | ~3.8 | n/a | Repositioning after the June Aerospace spin-off left a pure-play automation company; the headline P/E of 8 is distorted by the transaction, the forward figure is the fair read. |
| TMUS | $181.38 | 19.0 / 16.6 | 3.5 | n/a | Down 29% year over year as the merger-synergy rally deflates, but free-cash-flow yield screens cheap (P/FCF ~12) on steady postpaid additions. |
| AMT | $175.96 | 16.1 / 24.8 | 8.0 | Selling (dir.) | A rate-sensitive tower REIT well below its historical multiple as organic growth slows; leverage is high by design for the model. |
| ORCL | $149.70 | 25.9 / 18.8 | 10.1 | Selling (Vice-Chair) | A valuation reset after the AI-cloud run, with OCI up 93% and a reiterated $90B FY27 revenue target; debt-funded capex is the open question. |
| PG | $145.29 | 21.7 / n/a | 6.2 | 14 sells, 0 buys | Down 14% from the high on flat volumes; defensive cash returns continue at roughly $15B in FY26, but growth is only mid-single-digit. |
| PEP | $140.27 | 18.3 / 16.3 | 8.7 | Selling | Weak volumes across snacks and beverages; a 4% dividend and solid operating cash flow support the case while the top line stalls. |
| STZ | $130.79 | 10.9 / 11.2 | 2.6 | Selling | Mexican-beer weakness and a below-consensus guide; the optically low P/E is distorted by prior write-downs. |
| VST | $137.32 | 23.6 / 15.6 | 8.5 | Selling ($6.7M) | A pullback after the AI-power run; 44 GW of capacity and growing data-center contracts underpin demand, though insiders sold $6.7M in the quarter. |
| LULU | $121.57 | ~9.7 / 11.1 | 2.9 | Buying (dir. Bergh) | A record-low ~10x multiple driven by de-rating rather than falling demand; a director bought and Burry has built it to a ~17% position into the 3 September print. |
| WMT | $104.45 | 37.6 / 34.8 | 8.2 | Selling (EVP) | Its worst same-store sales in six years and a 9% drop, yet still on ~35x, richer than its own history; near the low, but not a value name. |
| NFLX | $81.54 | 23.5 / 22.8 | 11.3 | Selling | Down 35% year over year on fears the subscriber super-cycle is ending, though Q3 growth is still guided near 12%. |
| UBER | $76.07 | 16.7 / 23.0 | 5.7 | Selling | Strong Q2 revenue but a soft Q3 bookings guide took the stock 5% lower; profitable and free-cash-flow positive at ~17x trailing. |
| ZTS | $76.96 | 12.2 / 12.1 | 10.2 | Buying (2 execs) | Guidance cut in August and down ~40% YTD, leaving the multiple 66% below its ten-year average; two executives bought this defensive animal-health compounder. |
| KR | $57.70 | 33.3 / 10.9 | 5.5 | Selling (30k sh) | A high trailing P/E masks an ~11x forward multiple as the market prices an EPS recovery on steady grocery cash flows. |
| FI | ~$63 | 10.1 / 7.3 | 1.03 | Buying (CFO+CLO, first ever) | Near book value at a record-low multiple after the 6 August Q2 print cut the full-year outlook and flagged organic revenue that could turn negative in 2026, so this is part genuine deterioration, not only de-rating. The counterweight is the first-ever insider buying by the CFO and CLO and a Buy analyst consensus. |
| NKE | $39.11 | 18.3 / 23.1 | 3.9 | Buying (Tim Cook, dir.) | At a twelve-year low on a slow turnaround; director Tim Cook bought 25,000 shares, while the forward multiple already prices a recovery. |
| ROL | $36.36 | 32.7 / n/a | 12.2 | n/a | Down about 33% YTD as a premium multiple de-rates; steady pest-control cash flows, and the chairman's transaction was a gift rather than a sale. |
| CPRT | $33.23 | 20.5 / n/a | 3.7 | Selling (CEO, $6M+) | A leadership change and takeover interest have lifted it recently; the CEO has been a heavy seller and the auto-auction model stays cash-generative. |
| VICI | $25.76 | 10.0 / n/a | 0.96 | n/a | A casino REIT trading below book value with 95%+ margins and rents growing 3.5%; rate pressure is the drag on the shares. |
| SOFI | $17.84 | 39.1 / 30.3 | 2.1 | Selling | A post-rally reset, down 27% YTD, with book value up 40% year over year; a ~14% short float makes it a squeeze candidate on good news. |
| TTD | $13.71 | 16.0 / 11.6 | 2.5 | 4 buys / 3 sells | A vertical fall from ~$170 after a Q2 miss; the only name with net insider buying, and a 20% short float that cuts both ways. |
| SNAP | $5.52 | n/a / 10.4 | 4.7 | Selling (legal chief) | Negative EPS and decelerating ad revenue, but free cash flow has turned positive; priced at ~10x forward. |
| GRAB | $3.53 | 32.6 / 32.5 | 2.1 | Selling (CPO) | Post-IPO dilution weighs on sentiment despite $2.9B of cash, Q2 revenue up 22%, raised guidance and a $750M buyback. |
The insider signal is the clearest read on the list. Net buying shows up at Zoetis (two executives), Nike (director Tim Cook, 25,000 shares), Lululemon (a director, 6,090 shares), Fiserv (CFO and CLO, the first insider purchases on record) and The Trade Desk (four buys against three sells). The heaviest selling is at AppLovin (~$372M over six months) and at McDonald's and Procter & Gamble, with fifteen and fourteen sales and no purchases, alongside continuous selling at Copart, SoFi, Snap, Grab and Kroger.
The dominant driver is a multiple de-rating (TTD, LULU, NKE, ZTS, ROL, APP) or a cut to guidance (LOW, IBM, ZTS, UBER, WMT) rather than a breakdown in the underlying business; only a handful carry genuine operating problems, chiefly traffic at Snap and McDonald's, volumes at PepsiCo and beer at Constellation. On the balance sheet, VICI (P/B 0.96) and Fiserv (P/B 1.03) are the only two trading near book value, the widest margin of safety here, while Lowe's and McDonald's have negative book value from buybacks, which makes P/B unusable. Short interest is the other tell: The Trade Desk (20% of float) and SoFi (~14%) are the clearest squeeze candidates should sentiment turn.
Informational analysis based on public data as of 31 August 2026, not financial advice. P/E, P/B and any forward-growth figures are drawn from company guidance and analyst consensus and can differ materially from actual results. Always verify on primary sources before acting.
Educational market information, not financial advice. Some links on this site are affiliate links, always disclosed. Markets carry risk of loss.